Por: Los Angeles Times Science December 06, 2022
Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 — not as a booster but as part of their initial series of shots. Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine — each a tenth of the amount adults receive — as their primary series. If the Food and Drug Administration agrees, a dose of Pfizer's... + full article
Ars Technica USA Science December 10, 2022
Navigate Filter by topic Settings Front page layout Site theme - Dec 9, 2022 11:08 pm UTC / Reisa Lancaster RN, left, administers the Covid-19 vaccine to 14 month old Ada Hedge, center, being comforted by mom Sarah Close and dad Chinmay Hedge, right at Children's National... + más
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
New COVID booster authorization will sway parents to get young kids vaccinated, FDA vaccine chief hopes | ABC News
Politico USA Health December 08, 2022
The FDA on Thursday authorized emergency use of updated bivalent Covid-19 vaccines for children as young as 6 months old. The move to authorize bivalent shots made by Pfizer-BioNTech and Moderna comes as Covid-19 infections in the United States tick up amid the most intense flu... + más
Kids 5-11 can now get the bivalent, BA.5-targeting COVID booster | Ars Technica
FDA authorizes bivalent COVID-19 boosters for children as young as 6 months | WGN-TV
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
Newsweek USA Health November 02, 2022
Pfizer announced positive trial results on Tuesday for a vaccine designed to help protect against the respiratory syncytial virus, or RSV, potentially setting up the company to have the first shot of its kind to be approved against the virus.The exact timeline for the vaccine... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
NBC 6 South Florida USA World October 19, 2022
Hannah Beier Bloomberg Getty Images The Food and Drug Administration has authorized 's Covid boosters for adults in the U.S., including for people who received Pfizer's or Moderna's shots as their primary series. The authorization of Novavax's booster could... + más
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
The Hill USA Health September 28, 2022
Tonight, Jupiter will be the closest it’s been to Earth decades, and if the sky’s clear, you should be able to and some of its moons. In health news, Pfizer wants the FDA to authorize the omicron booster shot for kids ages 5 to 11. and . Someone forward you this... + más
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11 | CNBC
Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old | CNBC
About iurex | Privacy Policy | Disclaimer |